Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (18)

« Back to Publications

IGF-1 regulates cancer cell immune evasion in prostate cancer.

Nandakumar AM. et al, (2025), Sci Rep, 15

IRE1 activity regulates tumour and microenvironment cell lineage states while stratifying localised and metastatic prostate cancer

Doultsinos D. et al, (2025)

Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of epithelial cancers.

Erickson A. et al, (2025), PLoS One, 20

Accelerated and intensified manufacturing of an adenovirus-vectored vaccine to enable rapid outbreak response.

Joe CCD. et al, (2024), Biotechnol Bioeng, 121, 176 - 191

Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.

Figiel S. et al, (2023), Mol Cancer, 22

A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment.

Pelizzari-Raymundo D. et al, (2023), iScience, 26

Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of heterogeneity on genomic signature scoring

Figiel S. et al, (2023)

Dual IRE1 RNase functions dictate glioblastoma development.

Lhomond S. et al, (2023), EMBO Mol Med, 15

Spatially resolved clonal copy number alterations in benign and malignant tissue.

Erickson A. et al, (2022), Nature, 608, 360 - 367

Dual IRE1 RNase functions dictate glioblastoma development.

Lhomond S. et al, (2022), EMBO Mol Med, 14

Inhibition of CDK9 activity compromises global splicing in prostate cancer cells.

Hu Q. et al, (2021), RNA Biol, 18, 722 - 729

Peptidomimetic-based identification of FDA-approved compounds inhibiting IRE1 activity.

Doultsinos D. et al, (2021), FEBS J, 288, 945 - 960

Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges.

Doultsinos D. and Mills IG., (2021), Cancers (Basel), 13

Pharmacological Targeting of IRE1 in Cancer.

Raymundo DP. et al, (2020), Trends Cancer, 6, 1018 - 1030

The role of the androgen receptor as a driver and mitigator of cellular stress.

Doultsinos D. and Mills I., (2020), J Mol Endocrinol, 65, R19 - R33

Load More